会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • PARKING ASSISTANCE APPARATUS AND PARKING ASSISTANCE METHOD
    • 停车辅助设备和停车辅助方法
    • US20110298926A1
    • 2011-12-08
    • US13202004
    • 2010-02-25
    • Hiroshi KatsunagaKazunori ShimazakiTomio KimuraYutaka NakashimaKoji HikaKeisuke Inoue
    • Hiroshi KatsunagaKazunori ShimazakiTomio KimuraYutaka NakashimaKoji HikaKeisuke Inoue
    • H04N7/18
    • B62D15/027G06K9/00798G06K9/00912G06T7/73G06T2207/30208G06T2207/30264G08G1/16G08G1/168
    • Provided is a parking assistance apparatus utilizing a fixed target by taking an image thereof, the parking assistance apparatus being capable of recognizing the fixed target with high recognition accuracy while using simple image recognition processing. A mark (M) includes a plurality of illuminators (1). Sets of the plurality of illuminators (1) form characteristic points C1 to C4. Turn-ON request generation means (36) of a vehicle-side device (20) sequentially generates turn-ON requests for each characteristic point and transmits the generated turn-ON requests to a parking-lot-side device (10). A display control unit (11) of the parking-lot-side device (10) turns ON the characteristic points based on the turn-ON requests. An image recognition unit (31) of the vehicle-side device (20) performs image recognition for the characteristic points sequentially. Using the recognition result, positional parameter calculation means (34) of the vehicle-side device (20) calculates positional parameters of a camera with respect to the mark (M).
    • 提供一种通过拍摄图像来利用固定目标的停车辅助装置,在使用简单的图像识别处理的同时,能够以高识别精度识别固定目标的停车辅助装置。 标记(M)包括多个照明器(1)。 多个照明器(1)的组合形成特征点C1〜C4。 车辆侧设备(20)的接通请求产生装置(36)顺序地产生每个特征点的接通请求,并将生成的接通请求发送到停车场侧设备(10)。 停车场侧装置(10)的显示控制单元(11)基于接通请求接通特征点。 车辆侧装置(20)的图像识别单元(31)依次对特征点进行图像识别。 使用识别结果,车辆侧装置(20)的位置参数计算装置(34)计算相机相对于标记(M)的位置参数。
    • 12. 发明申请
    • CYCLIC AMINE DERIVATIVE HAVING SUBSTITUTED ALKYL GROUP
    • 具有取代的烷基的环胺衍生物
    • US20090306059A1
    • 2009-12-10
    • US11915522
    • 2006-05-26
    • Tomio KimuraNaoki TanakaHiroyuki KobayashiAtsuhiro Sugidachi
    • Tomio KimuraNaoki TanakaHiroyuki KobayashiAtsuhiro Sugidachi
    • A61K31/541C07D413/06A61K31/5377C07D417/06C07D401/06A61K31/4545A61P7/02
    • F16D3/2233F16D2003/22309Y10T403/32655
    • A compound having the general formula (I), pharmacologically acceptable salts thereof or prodrugs thereof: [wherein R1 represents a hydrogen atom, a C1-C6 alkyl group which may be substituted, a C3-C6 cycloalkyl group which may be substituted, a C1-C6 alkoxy group which may be substituted or a C6-C10 aryl group which may be substituted; R2 represents a hydrogen atom, a halogen atom, a carboxy group, a C2-C7 alkoxycarbonyl group, a carbamoyl group, a cyano group, a C1-C6 alkyl group, a halogeno C1-C6 alkyl group, a C1-C6 alkyl group substituted by a heteroaryl group, a C1-C6 alkoxy group, a halogeno C1-C6 alkoxy group, a hydroxy C1-C6 alkyl group, a C2-C12 alkoxyalkyl group, a formyl group, a C2-C7 alkanoyl group, a C4-C7 cycloalkylcarbonyl group, a C2-C7 alkylcarbamoyl group, a di(C1-C6 alkyl)carbamoyl group, a group of formula R4—CO—CR5R6—(CH2)m—, a group of formula R7—CO—(CH2)l—N(R8)— or a sulfamoyl C1-C6 alkyl group; R3 represents a substituted C1-C6 alkyl group, a heterocyclyl group or a heterocyclyl group substituted with 1 to 5 substituents; X1, X2, X3, X4 and X5 each independently represents a hydrogen atom, a halogen atom, an amino group, a carboxy group, a carbamoyl group, a cyano group, a nitro group, a C1-C6 alkyl group, a halogeno C1-C6 alkyl group, a C1-C6 alkoxy group, or a halogeno C1-C6 alkoxy group; and n represents an integer of 0 to 2].
    • 具有通式(I)的化合物,其药学上可接受的盐或其前药:其中R1表示氢原子,可被取代的C1-C6烷基,可被取代的C3-C6环烷基,C1 可被取代的-C6烷氧基或可被取代的C6-C10芳基; R2表示氢原子,卤素原子,羧基,C2-C7烷氧基羰基,氨基甲酰基,氰基,C1-C6烷基,卤代C1-C6烷基,C1-C6烷基 被杂芳基,C 1 -C 6烷氧基,卤代C 1 -C 6烷氧基,羟基C 1 -C 6烷基,C 2 -C 12烷氧基烷基,甲酰基,C 2 -C 7烷酰基, C7环烷基羰基,C2-C7烷基氨基甲酰基,二(C1-C6烷基)氨基甲酰基,式R4-CO-CR5R6-(CH2)m-的基团,式R7-CO-(CH2) (R8) - 或氨磺酰基C1-C6烷基; R 3表示取代的C 1 -C 6烷基,杂环基或被1至5个取代基取代的杂环基; X1,X2,X3,X4和X5各自独立地表示氢原子,卤素原子,氨基,羧基,氨基甲酰基,氰基,硝基,C1-C6烷基,卤代C1 C 1-6烷基,C 1 -C 6烷氧基或卤代C 1 -C 6烷氧基; n表示0〜2的整数]。
    • 14. 发明授权
    • Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
    • 杂芳基取代的吡咯衍生物,其制备及其治疗用途
    • US07122666B2
    • 2006-10-17
    • US10354648
    • 2003-01-30
    • Tomio KimuraAkira NakaoNobuyuki OhkawaTakayoshi NagasakiTakanori Yamazaki
    • Tomio KimuraAkira NakaoNobuyuki OhkawaTakayoshi NagasakiTakanori Yamazaki
    • C07D207/00C07D209/00
    • C07D451/02C07D401/04C07D401/14C07D453/02C07D455/02C07D471/04C07D487/04
    • Compounds having activity against production of an inflammatory cytokine of formula (I)′: A′ is pyrrole; R1′ is phenyl or naphthyl; R2′ is pyridyl or pyrimidinyl; R3′ is (IIa)′, (IIb)′ or (IIc)′: m′ is 1; E′ is nitrogen; D′ is >C(R5′)—, R5′ is hydrogen, Substituent α′ or Substituent β′; B′ is nitrogen-containing 5-membered heterocyclic; R4′ is 1 to 3 substituents from Substituent α′, Substituent β′ and Substituent γ′; R1′ and R3′ are bonded to two atoms of the pyrrole adjacent to the pyrrole atom bonded to R2′; Substituent α′ is hydroxyl, nitro, cyano, halogen, alkoxy, halogeno alkoxy, alkylthio, halogeno alkylthio or —NRa′Rb′; Ra′ and Rb′ are hydrogen, alkyl, alkenyl, alkynyl, aralkyl or alkylsulfonyl, or Ra′ and Rb′ with the nitrogen atom form a heterocyclyl; Substituent β′ is alkyl, alkenyl, alkynyl, aralkyl or cycloalkyl; Substituent γ′ is oxo, hydroxyimino, alkoxyimino, alkylene, alkylenedioxy, alkylsulfinyl, alkylsulfonyl, aryl, aryloxy, alkylidenyl or aralkylidenyl.
    • 具有抗式产生式(I)的炎性细胞因子的活性化合物的化合物:A'是吡咯; R 1是苯基或萘基; R 2是吡啶基或嘧啶基; (IIa)',(IIb)'或(IIc)':m'为1; E'是氮; D'是> C(R 5') - ,R 5'是氢,取代基α'或取代基β'; B'是含氮5元杂环; R 4'是1至3个取代基α',取代基β'和取代基γ'的取代基; R 1'和R 3'连接到与R 2'连接的吡咯原子相邻的吡咯的两个原子上; 取代基α'是羟基,硝基,氰基,卤素,烷氧基,卤代烷氧基,烷硫基,卤代烷硫基或-NR a R b B。 R a,O和R b'是氢,烷基,烯基,炔基,芳烷基或烷基磺酰基,或者R a'和R“ b'与氮原子形成杂环基; 取代基β'是烷基,烯基,炔基,芳烷基或环烷基; 取代基γ'是氧代,羟基亚氨基,烷氧基亚氨基,亚烷基,亚烷基二氧基,烷基亚磺酰基,烷基磺酰基,芳基,芳氧基,亚烷基或芳亚烷基。